LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing’s disease: results from a multicenter, proof-of-concept study - Bertagna, X; Pivonello, R; Fleseriu, M (J Clin Endocrinol Metab, 2014)
et al.